The Covid-19 pandemic has introduced an array of organspecific and systemic phenotypes-
some previously observed in viral infections, including severe acute respiratory syndrome …

Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …

There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …

Coronavirus disease of 2019 (COVID-19) is the clinical manifestation of the respiratory
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …

An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …

The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities
across the globe on an unprecedented scale. Patients have had diverse clinical outcomes …

Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19)
has posed a multitude of challenges to health care systems worldwide. In order to combat …

COVID-19 has proven to be particularly challenging given the complex pathogenesis of
SARS-CoV-2. Early data have demonstrated how the host response to this novel …

The current, global situation regarding the severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) pandemic and its potentially devastating clinical manifestations, ie …

Abstract Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …